Karuna Therapeutics Inc. (KRTX) Tops Q2 EPS by 1c

Karuna Therapeutics Inc. (NASDAQ: KRTX) reported Q2 EPS of ($2.75), $0.01 better than the analyst estimate of ($2.76).

For earnings history and earnings-related data on Karuna Therapeutics Inc. (KRTX) click here.

You May Also Be Interested In

• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• Dolphin Entertainment, Inc. (DLPN) Misses Q2 EPS by 16c
• Denison Mines Corp. (DNN) Tops Q2 EPS by 4c